Overview

Mechanism of Action Study for Psoriasis

Status:
Completed
Trial end date:
2017-05-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to compare the mechanism of action between adalimumab and methotrexate in subjects with psoriasis.
Phase:
Phase 4
Details
Lead Sponsor:
Tufts Medical Center
Treatments:
Adalimumab
Folic Acid
Methotrexate